Cannabidiol Preserves Retinal Neurons and Reduces Vascular Permeability in Experimental Diabetes     (abst – 2004)  http://abstracts.iovs.org/cgi/content/abstract/45/5/860?maxtoshow=&hits=80&RESULTFORMAT=&fullte  xt=cannabinoid&searchid=1&FIRSTINDEX=1760&resourcetype=HWCIT


The effect of WIN 55,212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats. (abst – 2004)                                          http://www.ncbi.nlm.nih.gov/pubmed/15519750


Cannabidiol lowers incidence of diabetes in non-obese diabetic mice                     (full – 2005)



Activation of the Peripheral Endocannabinoid System in Human Obesity (full – 2005)                                       http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228268/?tool=pmcentrez


Gpr40 Gene Expression in Human Pancreas and Insulinoma.                     (abst – 2005)



The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse.                                                                          (abst – 2005)  http://www.ncbi.nlm.nih.gov/pubmed/16054069


Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592672/?tool=pubmed


Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia                                                               (full – 2006)  http://jcem.endojournals.org/cgi/content/full/91/8/3171?ijkey=83a68cef202eafe129332eda53eee8eb613499 82


Weight Control in Individuals With Diabetes                       (full – 2006)  http://care.diabetesjournals.org/content/29/12/2749.full?maxtoshow=&hits=80&RESULTFORMAT=&full text=cannabis&searchid=1&FIRSTINDEX=2000&resourcetype=HWCIT









Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration.                                                         (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/17011761


Expression of the Gene for a Membrane-bound Fatty Acid Receptor in the Pancreas and Islet Cell Tumours in Humans: Evidence for Gpr40 Expression in Pancreatic Beta Cells and Implications for Insulin Secretion.                                                                              (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16525841


The Cannabinergic System as a Target for Anti-inflammatory Therapies

(abst – 2006)              http://www.ingentaconnect.com/content/ben/ctmc/2006/00000006/00000013/art00008


Non-Psychoactive Cannabinoid Reduces Incidence Of Diabetes, Study Says (news – 2006)                                     http://www.norml.org/index.cfm?Group_ID=6909


Marijuana Compound May Help Stop Diabetic Retinopathy              (news – 2006)



Cannabidiol, a marijuana compound, may help stop diabetic retinopathy             (news – 2006)



Marijuana Compound Offers Hope In Diabetic Retinopathy Prevention (news – 2006)  http://www.bio-medicine.org/medicine-news/Marijuana-Compound-Offers-Hope-In-Diabetic-Retinopathy-  Prevention-8121-1/


Cannabidiol reduces the development of diabetes in an animal study              (news – 2006)



Getting Eye On Cannabinoids              (news – 2006)



Marijuana compound could prevent eye damage in diabetics               (news – 2006)  http://www.thehempire.com/index.php/cannabis/news/marijuana_compound_could_prevent_eye_damage_i   n_diabetics


Compound found in marijuana may defend against diabetic retinopathy            (news – 2006)



Cannabidiol arrests onset of autoimmune diabetes in NOD mice               (full – 2007)



Expression of Cannabinoid CB1 Receptors in Models of Diabetic Neuropathy (full – 2007)

http://jpet.aspetjournals.org/content/323/2/508.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=  cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT


Cannabidiol attenuates high-induced endothelial cell inflammatory response and barrier disruption         (full – 2007)  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2228254&tool=pmcentrez










US Patent Application 20070099987 – Treating or preventing diabetes with cannabidiol (full – 2007)                                    http://www.patentstorm.us/applications/20070099987/fulltext.html


Role of cannabinoid CB2 receptors in glucose homeostasis in rats             (abst – 2007)



The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells                                          (abst – 2007)  http://lib.bioinfo.pl/pmid:17604177


Anticoagulant Effects of a Cannabis Extract in an Obese Rat Model             (abst – 2007)



Mediation of Cannabidiol anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor                                                  (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588644/?tool=pmcentrez


The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids                                                                    (full – 2008)  http://diabetes.diabetesjournals.org/content/57/5/1262.full?sid=00769f3d-54ab-451b-b69e-4650931c5e25


GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity        (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268073/?tool=pmcentrez


Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.                                                              (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528830/?tool=pubmed


Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet   (full – 2008)                         http://www.nature.com/oby/journal/v16/n3/full/oby2007106a.html


Neuroprotective effects of cannabidiol in endotoxin-induced uveitis: critical role of p38 MAPK activation.        (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592995/?tool=pubmed


Endocannabinoids and the Control of Energy Homeostasis             (full – 2008)



Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor                                                (full – 2008)  http://www.iovs.org/content/49/12/5526.full


Effect of anandamide in improving of the non-adrenergic non-cholinergic relaxation of the corpus cavernosum from diabetic rats                                                              (abst – 2008)  http://www.doaj.org/doaj?func=abstract&id=859448&q1=anandamide&f1=all&b1=and&q2=&f2=all&rec No=25&uiLanguage=en









Presence of functional cannabinoid receptors in human endocrine pancreas. (abst – 2008)                                     http://www.ncbi.nlm.nih.gov/pubmed/18092149


Cannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development. (full – 2009)    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955420/?tool=pubmed


Cannabinoids as novel anti-inflammatory drugs.              (full – 2009)



Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis                                                                  (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688760/?tool=pubmed


The endocanabinnoid system and diabetes – critical analyses of studies conducted with rimonabant         (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770455/?tool=pmcentrez


Biological effects of THC and a lipophilic cannabis extract on normal and insulin resistant 3T3-L1 adipocytes                                                          (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19345076/abstract/Biological_effects_of_THC_an  d_a_lipophilic_cannabis_extract_on_normal_and_insulin_resistant_3T3_L1_adipocytes_


Anti-inflammatory effect of palmitoylethanolamide on human adipocytes.            (abst – 2009)



Beneficial effects of a Cannabis sativa extract on diabetes induced neuropathy and oxidative stress.       (abst – 2009)  http://www.unboundmedicine.com/medline/ebm/record/19441010/abstract/Beneficial_effects_of_a_Canna bis_sativa_extract_treatment_on_diabetes_induced_neuropathy_and_oxidative_stress_


Cannabis plant extracts could potentially form the basic ingredients for a market-leading diabetes drug   (news – 2009)  http://www.thefreelibrary.com/Cannabis+plant+extracts+could+potentially+form+the+basic+ingredients…-  a0202701009


Medical Marijuana and Diabetes, Adult Onset              (news – 2009)



Expression and function of cannabinoid receptors in mouse islets.              (full – 2010)



Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain                                                       (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez


Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. (full – 2010)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed









Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy       (full – 2010)  http://diabetes.diabetesjournals.org/content/59/4/1046.full?sid=0bc8e3fa-5275-4b19-8acc-4aec5dfac384


Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects.                                                                (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003779/


Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells          (full – 2010)  http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=320527       &Ausgabe=25   4555&ProduktNr=224332&filename=320527.pdf


Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients                                                 (full – 2010)  http://www.lipidworld.com/content/9/1/43


Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. (full – 2010)                                    http://diabetes.diabetesjournals.org/content/59/11/2826.long#sec-25


Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes.        (full – 2010)                          http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925907/?tool=pubmed


Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy (full – 2010)         http://www.natap.org/2010/newsUpdates/marijuana.pdf


Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes?                                                      (full – 2010)  http://www.jci.org/articles/view/44099?search[abstract_text]=&search[article_text]=cannabinoid&search[a   uthors_text]=&search[fpage]=&search[title_text]=&search[volume]=


Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.                                                   (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868848/?tool=pubmed


Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation. (full– 2010)                                    http://www.wjgnet.com/1948-9358/full/v1/i1/12.htm


Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.                                                                 (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20937249


AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.                                                         (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20816753









Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.                                                                      (abst – 2010)  http://www.springerlink.com/content/g037q1lh40l15161/


Endocannabinoid (EC) Receptor, CB1, and EC Enzymes’ Expression in Primary Adipocyte Cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin           (abst – 2010)

http://www.degruyter.com/abstract/j/jpem.2010.23.issue-  10/jpem.2010.162/jpem.2010.162.xml?rskey=38kdx0&result=22&q=cannabinoid


G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population.                                                        (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20851297


GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders.  (abst – 2010)                              http://www.ncbi.nlm.nih.gov/pubmed/21094910


Pot Compound Mitigates Diabetic Cardiomyopathy               (news – 2010)



Cannabinoids inhibit and may prevent neuropathic pain in diabetes.               (news – 2010)



Lab Notes: Pot Has Benefits for Diabetic Hearts              (news – 2010)



A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. (full – 2011)                                  http://joe.endocrinology-journals.org/content/211/2/177.long


Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy.     (full – 2011)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161308/


Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice             (full– 2011)



Role for cannabinoid receptors in human proximal tubular hypertrophy.              (full– 2011)



The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia.    (full – 2011)  http://www.rjme.ro/RJME/resources/files/520311791795.pdf


Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis        (abst – 2011)                   http://diabetes.diabetesjournals.org/content/60/4/1055.abstract


Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic β-Cells               (abst – 2011)  http://diabetes.diabetesjournals.org/content/60/4/1198.abstract?sid=0bc8e3fa-5275-4b19-8acc-  4aec5dfac384









Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice.                                                           (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21340622


Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans.                                                             (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21564460/abstract/Cannabinoid_receptor_agonists



Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes. (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21484568/abstract/Cannabinoids_and_Endocannab   inoids_in_Metabolic_Disorders_with_Focus_on_Diabetes_


Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.                                               (abst – 2011)           http://www.ncbi.nlm.nih.gov/pubmed/21238581


Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression.                                                         (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21309057/abstract/Win_55212_2_reduces_cardiac

_ischaemia_reperfusion_injury_in_zucker_diabetic_fatty_rats:_role_of_cb2_receptors_and_cardiac_inos/e nos_expression_


GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms                                           (abst – 2011)  http://endo.endojournals.org/content/152/2/374.abstract?sid=c77be354-b90f-4368-9bb3-fea533824b24


Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease.                                                           (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21633404


Cannabidiol Dampens Streptozotocin-Induced Retinal Inflammation by Targeting of Microglial Activation                                                  (abst – 2011)  http://abstracts.iovs.org/cgi/content/abstract/52/6/1002?maxtoshow=&hits=80&RESULTFORMAT=&fullt  ext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT


The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.                                                 (abst – 2011)       http://www.ncbi.nlm.nih.gov/pubmed/22029844


The Endocannabinoid System: Plant-Derived Cannabinoids in Diabetes and Diabetic Complications.      (abst – 2011)                             http://www.ncbi.nlm.nih.gov/pubmed/22155112


TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.                                                                                              (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21752941


Takeda moves potential first-in-class diabetes drug into phase III             (news – 2011)











Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III.                                                                   (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289985/


The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.                                                    (full – 2012)



The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity. (full – 2012)                                      http://diabetes.diabetesjournals.org/content/61/2/281.long


Endocannabinoids measurement in human saliva as potential biomarker of obesity. (full – 2012)                                      http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409167/?tool=pubmed


Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series                                                       (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/


Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids                                                                        (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493609/


Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice                                                          (full – 2012)  http://www.dmsjournal.com/content/4/1/35


Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant (full – 2012)                                      http://www.nutritionj.com/content/11/1/50


Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids.                                                         (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372498/


Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice                                                        (full – 2012)         http://www.lipidworld.com/content/11/1/98


Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol                                            (link to PDF – 2012)  http://www.scirp.org/journal/PaperInformation.aspx?paperID=17302


Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.                                             (abst – 2012)           http://www.ncbi.nlm.nih.gov/pubmed/22609797


Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice.                                                   (abst – 2012)      http://www.ncbi.nlm.nih.gov/pubmed/22487302









Induction of Glucose Intolerance by Acute Administration of Rimonabant. (abst – 2012)                                    http://www.ncbi.nlm.nih.gov/pubmed/22678147


TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.                                                                         (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22374408


Stimulating beta cell replication and improving islet graft function by GPR119 agonists. (abst – 2012)                                      http://www.ncbi.nlm.nih.gov/pubmed/21902730


A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003)           (abst – 2012)

http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/S38.003?maxtoshow=&hit   s=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=180&sortspec=date&reso  urcetype=HWCIT


The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models (abst – 2012)



G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes.                                                           (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22138970


A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes.       (abst – 2012)                           http://www.ncbi.nlm.nih.gov/pubmed/22669289


Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent.                                                                                            (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22490067


An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo- controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.                                                                           (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22921260


The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity.                                             (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22943701


Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity.                                         (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22743603









Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. (abst – 2012)           http://www.ncbi.nlm.nih.gov/pubmed/22959964


New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance.                                                                             (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22674489


Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function.   (abst – 2012)                                  http://www.ncbi.nlm.nih.gov/pubmed/23078523


The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity                                                     (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1467-789X.2012.01026.x/abstract


Synthetic cannabinoid could treat pain in diabetes patients                     (news – 2012)  http://www.medwirenews.com/57/102248/Diabetes/Synthetic_cannabinoid_could_treat_pain_in_diabetes_ patients_.html


Study: Synthetic THC Analogue Mitigates Diabetic Neuropathy, Is ‘Well Tolerated’ In Patients   (news – 2012)

http://norml.org/news/2012/09/20/study-synthetic-thc-analogue-mitigates-diabetic-neuropathy-is-well-  tolerated-in-patients


New drug offers novel pain management therapy for diabetics.                     (news – 2012)  http://www.thefreelibrary.com/New+drug+offers+novel+pain+management+therapy+for+diabetics.-  a0306899453


Drug offers new pain management therapy for diabetics                     (news – 2012)



Is the cardiovascular system a therapeutic target for cannabidiol?                     (abst – 2013)



Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids (abst – 2013)  http://www.nature.com/neuro/journal/vaop/ncurrent/full/nn.3321.html

Share a link for